Dr Mahsa Shahidi

Research Fellow
Medicine, Westemad Clinical School


Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Read, S., Tay, E., Shahidi, M., O'Connor, K., Booth, D., George, J., Douglas, M. (2015). Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon Response. PloS One, 10(8), 1-16. [More Information]
  • Read, S., Tay, E., Shahidi, M., McLauchlan, J., George, J., Douglas, M. (2015). The Mechanism of Interferon Refractoriness During Hepatitis C Virus Infection and Its Reversal with a Peroxisome Proliferator-Activated Receptor [alpha] Agonist. Journal of Interferon and Cytokine Research, 35(6), 486-497. [More Information]
  • Shahidi, M., Tay, E., Read, S., Ramezani-Moghadam, M., Chayama, K., George, J., Douglas, M. (2014). Endocannabinoid CB1 antagonists inhibit hepatitis C virus production, providing a novel class of antiviral host-targeting agents. Journal of General Virology, 95(11), 2468-2479. [More Information]
  • Read, S., Tay, E., Shahidi, M., George, J., Douglas, M. (2014). Hepatitis C virus infection mediates cholesteryl ester synthesis to facilitate infectious particle production. The Journal of General Virology, 95(9), 1900-1910. [More Information]
  • van der Poorten, D., Shahidi, M., Tay, E., Sesha, J., Tran, K., McLeod, D., Milliken, J., Ho, V., Hebbard, L., Douglas, M., George, J. (2010). Hepatitis C Virus Induces the Cannabinoid Receptor 1. PloS One, 5(9), 1-10. [More Information]

2015

  • Read, S., Tay, E., Shahidi, M., O'Connor, K., Booth, D., George, J., Douglas, M. (2015). Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon Response. PloS One, 10(8), 1-16. [More Information]
  • Read, S., Tay, E., Shahidi, M., McLauchlan, J., George, J., Douglas, M. (2015). The Mechanism of Interferon Refractoriness During Hepatitis C Virus Infection and Its Reversal with a Peroxisome Proliferator-Activated Receptor [alpha] Agonist. Journal of Interferon and Cytokine Research, 35(6), 486-497. [More Information]

2014

  • Shahidi, M., Tay, E., Read, S., Ramezani-Moghadam, M., Chayama, K., George, J., Douglas, M. (2014). Endocannabinoid CB1 antagonists inhibit hepatitis C virus production, providing a novel class of antiviral host-targeting agents. Journal of General Virology, 95(11), 2468-2479. [More Information]
  • Read, S., Tay, E., Shahidi, M., George, J., Douglas, M. (2014). Hepatitis C virus infection mediates cholesteryl ester synthesis to facilitate infectious particle production. The Journal of General Virology, 95(9), 1900-1910. [More Information]

2010

  • van der Poorten, D., Shahidi, M., Tay, E., Sesha, J., Tran, K., McLeod, D., Milliken, J., Ho, V., Hebbard, L., Douglas, M., George, J. (2010). Hepatitis C Virus Induces the Cannabinoid Receptor 1. PloS One, 5(9), 1-10. [More Information]

To update your profile click here. For support on your academic profile contact .